Leading international research centre in infection and immunity. CERCA centre.
IrsiCaixa is a leading international research center dedicated to innovation in infection and immunity. As a distinguished CERCA center, IrsiCaixa is at the forefront of biomedical research, committed to advancing scientific knowledge and improving global health outcomes.
Located at the Hospital Germans Trias i Pujol, Ctra del Canyet, s/n, Badalona, Barcelona 08916, ES, IrsiCaixa brings together a team of over 100 dedicated researchers. The institute leverages its extensive knowledge in immunology and vaccines to combat a broad spectrum of diseases, from HIV/AIDS to COVID-19, syphilis, Ebola, and beyond. The institute's scientific trajectory has led it to engage in other cross-cutting disciplines, such as understanding the role of microorganisms and the resulting immunological disorders to address medical challenges like cancer, Alzheimer's, aging, and the microbiome.
IrsiCaixa maintains a strong commitment to eradicating infectious diseases and improving patient outcomes worldwide. We invite the management of IrsiCaixa to create a customized and exclusive company showcase and product listing on our platform to further amplify their impact and reach.
IrsiCaixa es un centro de investigación internacional líder dedicado a la innovación en infección e inmunidad. Como un distinguido centro CERCA, IrsiCaixa está a la vanguardia de la investigación biomédica, comprometido con el avance del conocimiento científico y la mejora de los resultados de salud a nivel mundial.
Ubicado en el Hospital Germans Trias i Pujol, Ctra del Canyet, s/n, Badalona, Barcelona 08916, ES, IrsiCaixa reúne a un equipo de más de 100 investigadores dedicados. El instituto aprovecha su amplio conocimiento en inmunología y vacunas para combatir un amplio espectro de enfermedades, desde el VIH/SIDA hasta la COVID-19, la sífilis, el ébola y más allá. La trayectoria científica del instituto lo ha llevado a participar en otras disciplinas transversales, como la comprensión del papel de los microorganismos y los trastornos inmunológicos resultantes para abordar desafíos médicos como el cáncer, el Alzheimer, el envejecimiento y el microbioma.
IrsiCaixa mantiene un firme compromiso con la erradicación de las enfermedades infecciosas y la mejora de los resultados de los pacientes en todo el mundo. Invitamos a la dirección de IrsiCaixa a crear una presentación de empresa y un listado de productos personalizados y exclusivos en nuestra plataforma para amplificar aún más su impacto y alcance.
Compare IrsiCaixa with 3 companies in Research-Services
| Comparison Field |
IrsiCaixaMain Company |
The Jackson Laborato...View Profile |
Sorrento Therapeutic...View Profile |
Aging-USView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1929 | 2009 | 2009 |
|
Company Size
|
— | 1,001-5,000 | 501-1,000 | 11-50 |
|
City
|
Badalona, Barcelona | Bar Harbor, ME | San Diego, California | Orchard Park, New York |
|
Country
|
Spain | United States | United States | |
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Infection Research
Immunology
Vaccine Development
Biomedical Research
Infectious Diseases
Microbiome Research
HIV/AIDS Research
microbiome
biomedical research
HIV/AIDS
COVID-19
cancer
aging
hepatitis
infectious diseases
|
14 Total
14 Unique
Unique Skills:
bioinformatics
computational biology
developmental biology
eye research
genetics
genomic medicine
+8
|
3 Total
3 Unique
Unique Skills:
Biopharma
Diagnostics
Non-opioid pain management
|
15 Total
15 Unique
Unique Skills:
age-related diseases
anti-aging strategies
cellular senescence
DNA damage response & repair
drug development
evolution of aging
+9
|
Other organizations in the same industry
This company is also known as